BB Biotech AG 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 10:13 am Unchanged | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 4,494,458 3.700% | 0 (Unchanged) | Filing |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 4,494,458 5.200% | -108,400 (-2.36%) | Filing |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 4,602,858 7.800% | 2,000,000 (+76.84%) | Filing |
| 2021-02-12 4:48 pm Purchase | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 2,602,858 5.300% | 200,000 (+8.32%) | Filing |